Geneva, Switzerland – May 122022 – ObsEva SA (OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that it plans to host a conference call on Tuesday, May 17, 2022 at 8:00 a.m. ET to discuss its financial results for the quarter ended May 31, 2022. March 2022 and provide a company update.
Individuals can participate by phone by dialing (877) 300-8521 (domestic) or +1 (412) 317-6026 (international) and using conference ID 10166576. The webcast can be accessed live here and will also be accessible in the “Events Calendar” section of the ObsEva’s investors section website. The webcast will be archived on the company’s website for at least 30 days after the conference call.
ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s health. Through strategic licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on novel therapies for the treatment of uterine fibroids, endometriosis and preterm labor. ObsEva is listed on the Nasdaq Global Select Market and trades under the symbol “OBSV” and on the SIX Swiss Exchange where it trades under the symbol “OBSN”. For more information, please visit www.ObsEva.com
For more information, please contact:
CEO office contact details
+41 22 552 1550
+1 (917) 969-3438